BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT05558319 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2022-10-01 → 2022-11-10 3. collaborators added: Adknoma Health Research 4. collaborators removed: Start from scratch, Adknoma
Clinical trial NCT05558319 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2022-10-01 → 2022-11-10 3. collaborators added: Adknoma Health Research 4. collaborators removed: Start from scratch, Adknoma
Clinical trial NCT06100952 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-11-01 → 2026-03-17 3. primary completion date: 2025-11-01 → 2026-02-13 4. enrollment: 400 → 398 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06227546: completion date: 2026-05-01 → 2027-04-01.
Clinical trial NCT06165510 updates: 1. completion date: 2026-10-01 → 2026-11-01 2. primary completion date: 2026-06-01 → 2026-11-01
Clinical trial NCT06673238 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-04-01 → 2026-06-01 3. primary completion date: 2026-04-01 → 2026-06-01 4. enrollment: 96 → 95 participants 5. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07155668 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-11-01 → 2026-05-28 3. primary completion date: 2026-07-01 → 2026-05-28
Clinical trial NCT07504601: start date: 2026-06-29 → 2026-06-30.
Clinical trial NCT06215716 updates: 1. completion date: 2032-11-01 → 2033-02-01 2. primary completion date: 2032-11-01 → 2033-02-01
Clinical trial NCT07216482: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT05742802 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-28 → 2026-05-27